A comprehensive view of Acuitas Therapeutics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer and Acuitas Therapeutics enter agreement under which Pfizer will have option to license Acuitas' lipid nanoparticle technology for up to 10 targets for vaccine or therapeutic development; technology is a delivery system for mRNA-based therapies
Published: January 10, 2022 by Pfizer Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count